CD1C and diffuse large B-cell lymphoma: Prognostic analysis of DLBCL clinical samples showed that patients with high CD1c expression at the mRNA level had a poor prognosis, and the same was true for patients with high CD1c expression at the protein level, but the difference was not statistically significant.